In pre-clinical models of non-alcoholic steatohepatitis (NASH)-associated HCC, exhausted, unconventionally activated PD1+ CD8 T cells were related to impaired tumour surveillance, causing tissue damage and facilitating, rather than inhibiting, hepatocarcinogenesis upon anti-PD1 treatment23. The gene discussed is CD8A; the disease is hepatocellular carcinoma.